Ceritinib is an anaplastic lymphoma kinase (ALK)-positive inhibitor primarily used for the treatment of metastatic NSCLC. Previously, it was only indicated for patients who had developed resistant to crizotinib, another ALK-positive inhibitor, but has since had its usage expanded to serve as a primary option for metastatic NSCLC.
Chemocare.com uses generic names in all descriptions of drugs. Ceritinib is the generic for the trade chemotherapy drug Zykadia™. In some cases, health care professionals may use the trade name Zykadia™ when referring to the generic drug name ceritinib.
Ceritinib is used to treat a certain type of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. Ceritinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of cancer cells.
we are Ceritinib manufacturers，If you want to wholesale Ceritinib，pls contact us.
